Drug/cyclodextrin/hydroxy acid multicomponent systems. Properties and pharmaceutical applications.

The objective of this mini-review is to summarize the findings concerning the properties and the pharmaceutical applications of multicomponent complexes made of a sparingly water-soluble amino-type drug, a cyclodextrin, and a hydroxy carboxylic acid. Simultaneous complexation and salt formation with these acids significantly increase the solubilizing power, allowing us to reduce the amount of cyclodextrin necessary for making the targeted formulation. In many cases, the aqueous solubility of the hydrophobic drug can be enhanced by several orders of magnitude, while that of CD can be enhanced more than 10-fold. The mechanism through which these complexes elicit their synergetic effects on the drug solubility is also discussed. Finally, some general observations are made concerning the structural requirements of the drug necessary for exploiting the aforementioned effect.

[1]  T Nagai,et al.  Enhancement of bioavailability of cinnarizine from its beta-cyclodextrin complex on oral administration with DL-phenylalanine as a competing agent. , 1985, Journal of pharmaceutical sciences.

[2]  B. Casetta,et al.  Study of the salts with organic hydroxy acids of the terfenadine β-cyclodextrin inclusion complex in solution by lonspray mass spectrometry , 1995 .

[3]  É. Fenyvesi,et al.  Interaction of Hydroxy Acids with β-Cyclodextrin , 1999 .

[4]  J. Bello,et al.  Characterization of multicomponent mixtures of polynuclear aromatic hydrocarbons with .alpha.-cyclodextrin-induced solid-surface room-temperature luminescence , 1988 .

[5]  J. Szejtli.  The properties and potential uses of cyclodextrin derivatives , 1992 .

[6]  J. Szejtli,et al.  Fendiline-β-Cyclodextrin inclusion complex , 1985 .

[7]  Keishiro Shirahama,et al.  Interactions of amphiphilic drugs withα-,β-, andγ-cyclodextrins , 1993 .

[8]  J. L. Vila-jato,et al.  Preparation and evaluation of ketoconazole-β-cyclodextrin multicomponent complexes , 1996 .

[9]  B. D. Anderson,et al.  Solubilization of a tripeptide HIV protease inhibitor using a combination of ionization and complexation with chemically modified cyclodextrins. , 1994, Journal of pharmaceutical sciences.

[10]  T. Kondo,et al.  A Study of Cyclodextrin Complex Formation by a Freezing Point Depression Method , 1993 .

[11]  Wolfram Saenger,et al.  Cyclodextrin Inclusion Compounds in Research and Industry , 1980 .

[12]  P. Ventura,et al.  Mutual Solubility Enhancement by Binary and Multicomponent Complexation of Clomiphene and Tamoxifen , 1999 .

[13]  T. Nagai,et al.  Evaluation of bioavailability upon oral administration of cinnarizine-beta-cyclodextrin inclusion complex to beagle dogs. , 1985, Chemical & pharmaceutical bulletin.

[14]  J. Szejtli,et al.  Cyclodextrins in Pharmacy , 1993 .

[15]  B. Perly,et al.  Investigation of the dynamics of cyclodextrins and their inclusion complexes in water by deuterium NMR , 1994 .

[16]  T. Loftsson,et al.  The effect of water-soluble polymers on drug-cyclodextrin complexation , 1994 .

[17]  G. Fazio,et al.  Solubility and solubilization properties of non-steroidal anti-inflammatory drugs , 1995 .

[18]  Géraldine Piel,et al.  Development of a non-surfactant parenteral formulation of miconazole by the use of cyclodextrins , 1998 .

[19]  S. Yalkowsky,et al.  Combined effect of complexation and pH on solubilization. , 1998, Journal of pharmaceutical sciences.

[20]  J. L. Vila-jato,et al.  Improvement in the Dissolution Properties of Ketoconazole Through Multicomponent β-Cyclodextrin Complexation , 1996 .

[21]  J. Szejtli.  Introduction and General Overview of Cyclodextrin Chemistry. , 1998, Chemical reviews.

[22]  B. Casetta,et al.  Study of β‐cyclodextrin–ketoconazole–tartaric acid multicomponent non‐covalent association by positive and negative ionspray mass spectrometry , 1998 .

[23]  L Delattre,et al.  Comparison of the IV pharmacokinetics in sheep of miconazole-cyclodextrin solutions and a micellar solution. , 1999, International journal of pharmaceutics.

[24]  J. Szejtli.  Cyclodextrins and their inclusion complexes , 1982 .

[25]  Thorsteinn Loftsson,et al.  The effect of hydroxypropyl methylcellulose on the release of dexamethasone from aqueous 2-hydroxypropyl-β-cyclodextrin formulations , 1994 .

[26]  J. Zung,et al.  ALCOHOL SIZE AS A FACTOR IN THE TERNARY COMPLEXES FORMED WITH PYRENE AND BETA -CYCLODEXTRIN , 1991 .

[27]  J. Pitha,et al.  Effects of ethanol on formation of inclusion complexes of hydroxypropylcyclodextrins with testosterone or with methyl orange , 1992 .

[28]  J. Pitha,et al.  Preparation of drug: hydroxypropylcyclodextrin complexes by a method using ethanol or aqueous ammonium hydroxide as co-solubilizers , 1992 .

[29]  M. Brewster,et al.  Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. , 1996, Journal of pharmaceutical sciences.

[30]  B. Müller,et al.  Complexation of dihydroergotamine mesylate with cyclodextrin derivatives: Solubility and stability in aqueous solution , 1995 .

[31]  Y. L. Loukas,et al.  Novel liposome-based multicomponent systems for the protection of photolabile agents , 1995 .

[32]  M. Mor,et al.  Experimental and theoretical analysis of the interaction of (+/-)-cis-ketoconazole with beta-cyclodextrin in the presence of (+)-L-tartaric acid. , 1999, Journal of pharmaceutical sciences.

[33]  T. Nagai,et al.  Physicochemical properties and inclusion complex formation of δ-cyclodextrin , 1995 .

[34]  M. Bilal,et al.  Beta-cyclodextrin/citric acid complexation equilibrium: thermodynamic study. Apparent solubility of βCD in aqueous solutions of citric acid , 1995 .

[35]  B. Müller,et al.  Interaction of NSA with cyclodextrins and hydroxypropyl cyclodextrin derivatives , 1991 .

[36]  C. Rhodes,et al.  Studies of the effect of pH, temperature and ring size on the complexation of phenytoin with cyclodextrins. , 1988, Pharmaceutica acta Helvetiae.

[37]  T. Loftsson,et al.  The Influence of water-soluble polymers and pH on hydroxypropyl-β-cyclodextrin complexation of drugs , 1996 .

[38]  Kennath A. Connors.  Cyclodextrins and their industrial uses: Dominique Duchêne (Editor), Editions de Santé, 19 rue Louis-le-Grand, 75002 Paris, France, 1987, 448 pages, ISBN 2-86411-019-9. , 1988 .

[39]  J. Blake,et al.  Inclusion complexation of ziprasidone mesylate with beta-cyclodextrin sulfobutyl ether. , 1998, Journal of pharmaceutical sciences.

[40]  A. Coleman,et al.  Aggregation of cyclodextrins: An explanation of the abnormal solubility ofβ-cyclodextrin , 1992 .

[41]  I. Warner,et al.  Influence of alcohols on the .beta.-cyclodextrin/acridine complex , 1993 .